Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RCKT, RCKTW | ROCKET PHARMACEUTICALS, INC. | CEO, Director | $19.1M | -$1.16M | -5.71% | Nov 21, 2024 |
TRML | Tourmaline Bio, Inc. | Director | Jun 13, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|